Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.
Paul Chen

Dr. Paul Chen MD

Ophthalmologist, North County Laser Eye Associates

What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Member of the Healthcare Council

Council Member Biography

Paul Chen, MD, is an Ophthalmologist at North County Laser Eye Associates in San Diego County, California. He provides comprehensive eye care with a focus on cataracts, glaucoma, eyelid enhancements, and laser vision correction. Dr. Chen has expertise in the latest medical and surgical techniques such as LASIK, Epi-LASIK, LASEK, PRK, AlphCor corneal implants, corneal transplants, glaucoma surgery, eyelid surgery, and cataract surgery with deluxe lens implants such as the ReStor, ReZoom, and Crystalens. He has a Visx S4 laser with Wavescan on site in his office. Dr. Chen holds two US patents and is active in basic research and clinical trials. He has previously worked with experts in laser vision correction at Stanford University and Nordan Laser Eye. Dr. Chen trained at Princeton University, Harvard Medical School, and the UCSF Department of Ophthalmology. (This is me - Update Profile)


Employment History

2004 - Unspecified
Ophthalmologist, North County Laser Eye Associates
2002 - 2003
Ophthalmologist, Dr. Jeffrey Nilles
2000 - 2002
Ophthalmologist, Pacific Eye Specialists
2000 - 2001
Opthalmologist, Premier Eye Care, San Francisco
2000 - 2000
Opthalmologist, Eye Medical Clinic

GLG NewsSM Analyses by Paul Chen(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

Cell Transfer Device for Corneal Wound Healing

July 25, 2007

New Method Of Adult Stem Cell Growth Treats Cornea Disorders | www.sciencedaily.com

I have been working on a cell transfer device designed to optimize wound healing after PRK laser vision correction. Essentially, we plan to coat a silicone hydrogel contact lens with a thin dissolvable layer of collagen on the concave surface. Cultured epithelial cells would be seeded onto the collagen layer, and the device would be placed onto the human eye after PRK laser vision correction. Tissue adhesive or sutures would be used to secure the peripheral portion of the device onto the eye. Collagenases in the tear film would dissolve the collagen layer, similar to their action upon collagen shields. The live epithelial sheet would transfer onto the corneal stroma and adhere after 24-72 hours. The contact lens secured to the eye would protect the epithelial sheet while allowing the patient to see as he/she was healing. The contact lens would be removed after the epithelium was successfully transferred.

Leading institutions connect with Paul Chen through GLG

GLG Live Meetings with Paul Chen(?)

Paul Chen has not participated in any GLG Live Meetings.

View all GLG Live Meetings in Healthcare